A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Insulin Market to exceed US$ 31.5 Bn by 2035, expanding at 4.1% CAGR, driven by rising diabetes prevalence and growing access to advanced ...

AUSTIN, TX, UNITED STATES, August 22, 2025 /EINPresswire.com/ -- Overview of the Market: The Global Biopharmaceuticals Market ...

The Global Diabetic Neuropathy Market is expected to reach at a CAGR of 6.7% during the forecast period (2024-2031). The ...